Standard BioTools™ invites you to register for two great back-to-back events showcasing new findings in immuno-oncology and cancer research.
Join us to hear expert investigators present their work and participate in panel discussions around their use of CyTOF® technology to gain new insights into both solid and liquid tumor biology.
Registration is limited and required for each event individually.
CyTOF Summit:
- Tuesday, June 14
- 7:00–10:45 am PT
- Read Agenda
- Register
IMC Forum:
- Wednesday, June 15
- 7:30–9:30 am PT
- Read Agenda
- Register
CyTOF Summit
Tuesday, June 14
07:00–10:45 PT | 10:00–13:45 ET | 15:00–18:45 BST | 16:00–19:45 CET
In this first installment of the 2022 CyTOF Summit, we are bringing together investigators from academia, pharma and biotech with a focus on oncology and immunology. These experts will share their clinically relevant research studies, data analysis approaches and technical applications.
The panel discussion portion of the Summit will provide the opportunity for you to ask questions of these experts and learn more about how CyTOF technology can enable your research.
IMC Forum
Wednesday, June 15
07:30–9:30 PT | 10:30–12:30 ET | 15:30–17:30 BST | 16:30–18:30 CET
Exploration of the tumor microenvironment (TME) is key to understanding the spatial relationships between cells and cell function in cancer pathology. In this IMC™ Forum we will begin with a conversation about the impact of adding Imaging Mass Cytometry™ to the Lombardi Comprehensive Cancer Center at Georgetown University, followed by two presentations that showcase research projects in hepatocellular carcinoma and colon cancer.
In the panel discussion, three expert researchers will share their experiences and insights, and give you an opportunity to ask questions so you can learn more about the potential advantages of IMC powered by CyTOF technology for your research.

CyTOF Summit Agenda (All times shown in PT)
Welcome and Introduction
→ 7:05–7:15
Andrew Quong, PhD
Chief Science Officer
Standard BioTools
Jonathan Irish, PhD
Associate Professor of Cell and Developmental Biology
Associate Professor of Pathology, Microbiology and Immunology
Vanderbilt University
Technical Applications
→ 7:15–8:05
High-Content Cytometry Solutions for Investigation, Discovery and Therapeutic Development in Immuno-Oncology
Roberto Spada, PhD
Director of Marketing, EMEA
Standard BioTools
Customization of the Maxpar® Direct™ Immune Profiling Assay™ and Maxpar Pathsetter™ for Use in a Biotech Setting
Pedro Estrada, MS
2seventy bio™
Simultaneous Quantification of Multiple Targets With Mass Cytometry to Support Biotherapeutic Drug Development
Chad Stevens, MS
Senior Scientist
Pfizer Worldwide Research & Development
Research Presentations
8:20–10:05
Connecting Cells to Patient Outcomes
Jonathan Irish, PhD
Vanderbilt University
An Unsupervised Learning Approach to Quantifying T Cell States from High-Plex Cytometry Data in Cancer Immunotherapy Clinical Trials
Dimitrios Sidiropoulos
PhD Candidate
Johns Hopkins School of Medicine
Cellular Microenvironments in Stem Cell Niche Contacting Glioblastoma
Rebecca Ihrie, PhD
Associate Professor of Cell and Developmental Biology
Associate Professor of Neurological Surgery
Vanderbilt University
Immune Correlates of GD2 CAR T Cell Expansion in Pediatric Osteosarcoma and Neuroblastoma Patients
Sneha Ramakrishna, MD
Instructor of Pediatrics, Division of Hematology and Oncology
Center for Cancer Cell Therapy, Stanford University School of Medicine
Panel Discussion
→ 10:10–10:45
Moderator: Rebecca Ihrie, PhD
Vanderbilt University

IMC Forum Agenda (All times shown in PT)
Welcome and Introduction
→ 7:30–7:35
Clinton Hupple, MSc
Product Manager
Standard BioTools
One-on-One Conversation on the Impact of Imaging Mass Cytometry Capabilities at a Cancer Center
→ 7:35–8:00
Stephen Byers, PhD
Professor of Oncology and Associate Director
Georgetown Lombardi Comprehensive Cancer Center
Andrew Quong, PhD
Chief Science Officer
Standard BioTools
Understanding the Immune Microenvironment of Hepatocellular Carcinoma Using Imaging Mass Cytometry
→ 8:00–8:25
Won Jin Ho, MD
Assistant Professor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Deciphering the Complexity of Anti-Cancer Immune Responses With Imaging Mass Cytometry
→ 8:25–8:50
Marieke Ijsselsteijn
PhD Candidate
Leiden University Medical Center
Panel Discussion
→ 8:50–9:25
Moderator: Michelle Macpherson
Director, Product Management, Imaging Mass Cytometry
Standard BioTools
Panelists:
- Stephen Byers, PhD
- Won Jin Ho, MD
- Marieke Ijsselsteijn
Session Close
→ 9:25
Clinton Hupple, MSc
Product Manager
Standard BioTools
FEATURED PRODUCTS
`
CyTOF XT™
Reimagine cytometry
Fully automated and affordable cytometry by time-of-flight. Simplify and standardize your deep single-cell profiling studies.
Hyperion™ Imaging System
Visualize spatial biology
Better understand the complex spatial biology of the tissue microenvironment with Imaging Mass Cytometry.
For Research Use Only. Not for use in diagnostic procedures. Patent and License Information: www.standardbio.com/legal/notices. Trademarks: www.standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2025 Standard BioTools Inc. All rights reserved.